Metronidazole

Pouchitis, Liver Abscess, Amebic, Lung Abscess + 53 more

Treatment

41 FDA approvals

20 Active Studies for Metronidazole

What is Metronidazole

Metronidazole

The Generic name of this drug

Treatment Summary

Metronidazole is a commonly used antibiotic, belonging to the nitroimidazole class of antibiotics.[L3754] It is frequently used to treat gastrointestinal infections as well as trichomoniasis and giardiasis, and amebiasis which are parasitic infections.[A181036,A181039] Metronidazole has been used as an antibiotic for several decades[L7429], with added antiparasitic properties that set it apart from many other antibacterial drugs, allowing it to treat a wide variety of infections. It is available in capsule form, tablet form, and topical form, and suppository preparations for the treatment of various infections.

Flagyl

is the brand name

image of different drug pills on a surface

Metronidazole Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Flagyl

Metronidazole

1963

449

Approved as Treatment by the FDA

Metronidazole, commonly known as Flagyl, is approved by the FDA for 41 uses including Bone and Joint Infections and Abscess .

Bone and Joint Infections

Abscess

Liver Abscess

Communicable Diseases

Osteomyelitis

Bacterial Endocarditis

Helicobacter Pylori Infection

Used to treat Helicobacter Pylori Infection in combination with Bismuth subsalicylate

Abdominal Abscess

Abdominal Infection

Skin and skin structure infections

Gynaecological infection

Lung Abscess

Endometritis

Central Nervous System Bacterial Infections

Bacterial Meningitis

Pneumonia

intra-abdominal bacterial infections

hepatic abscess

Tubo-ovarian abscess

Lung Abscess

Curling Ulcer

Used to treat Duodenal Ulcer in combination with Bismuth subsalicylate

Lower respiratory tract infection bacterial

Bacterial Septicemia

Bacteria, Anaerobic

Bacterial Infections

Duodenal Ulcer

Used to treat Duodenal Ulcer in combination with Bismuth subsalicylate

Meningitis

Abscess, Intra-Abdominal

Empyema

asymptomatic Trichomoniasis

Exposure via partner

Endomyometritis

Bacterial Peritonitis

Central Nervous System Bacterial Infections

Empyema

Trichomonas Infections

Endometritis

Endometritis

Bacteria

Endocarditis, Bacterial

Communicable Diseases

When to interrupt dosage

The prescribed dose of Metronidazole is contingent upon the determined condition, for instance Amoebiasis, Giardiasis and Trichomonas Vaginitis. The amount of dosage varies, in accordance with the technique of delivery featured in the table below.

Condition

Dosage

Administration

Vulvovaginitis

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Tubo-ovarian abscess

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Uterine Cervicitis

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Trichomonas Vaginitis

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Bacterial Vaginosis

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Pouchitis

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Giardiasis

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Bacterial Peritonitis

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Vaginitis

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Bacterial Septicemia

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Candida albicans

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Communicable Diseases

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

post-surgical vaginal cuff infection

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Inflammatory Papule

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Exposure via partner

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Bacterial Meningitis

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Sinusitis

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Endocarditis, Bacterial

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Operative Surgical Procedures

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Lockjaw

5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg

Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel - Topical, Topical, Gel, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Lotion - Topical, Lotion, Solution - Intravenous, Capsule, Capsule - Oral, Vaginal, Gel - Vaginal, Kit, Suppository, Suppository - Vaginal, Cream - Vaginal, Tablet, film coated, Suppository - Rectal, Tablet, coated, Tablet, coated - Oral, Injection - Intravenous, Kit - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Ointment, Ointment - Topical, Insert - Vaginal, Insert, Solution, Tablet, film coated - Oral, Tablet, extended release - Oral, Tablet, extended release, Rectal

Warnings

Metronidazole Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Metronidazole may interact with Pulse Frequency

Pregnancy Trimester, First

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Metronidazole may interact with Pulse Frequency

There are 20 known major drug interactions with Metronidazole.

Common Metronidazole Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be decreased when combined with Metronidazole.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Metronidazole.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Metronidazole.

Alpelisib

Major

The metabolism of Alpelisib can be decreased when combined with Metronidazole.

Aminophylline

Major

The metabolism of Aminophylline can be decreased when combined with Metronidazole.

image of a doctor in a lab doing drug, clinical research

Metronidazole Novel Uses: Which Conditions Have a Clinical Trial Featuring Metronidazole?

Two active trials are researching the potential of Metronidazole in combating Postoperative Infections, Urethritis trichomonal and Amoebiasis.

Condition

Clinical Trials

Trial Phases

Lockjaw

0 Actively Recruiting

Uterine Cervical Erosion

0 Actively Recruiting

Gum Disease

2 Actively Recruiting

Not Applicable

Abdominal Infection

0 Actively Recruiting

Rosacea

0 Actively Recruiting

Balantidiasis

0 Actively Recruiting

Empyema

1 Actively Recruiting

Phase 4

Abdominal Abscess

2 Actively Recruiting

Phase 4, Phase 1, Phase 2

Bacteria

0 Actively Recruiting

Trichomonas Infections

0 Actively Recruiting

Vulvovaginitis

0 Actively Recruiting

Lung Abscess

0 Actively Recruiting

Pouchitis

5 Actively Recruiting

Early Phase 1, Phase 4, Phase 2

Atopic Dermatitis

15 Actively Recruiting

Phase 2, Phase 3, Not Applicable, Phase 4, Phase 1

Acne Vulgaris

0 Actively Recruiting

Operative Surgical Procedures

0 Actively Recruiting

Liver Abscess, Amebic

0 Actively Recruiting

Trichomonas Vaginitis

2 Actively Recruiting

Phase 2, Phase 4

Amebic colitis

0 Actively Recruiting

Rosacea

2 Actively Recruiting

Early Phase 1, Phase 2

Metronidazole Reviews: What are patients saying about Metronidazole?

5

Patient Review

8/25/2022

Metronidazole for Vaginosis caused by Bacteria

This medication has cured my BV three times. It's absolutely amazing how quickly it works; the first day I could already tell a difference, and by the second day I felt even better. This is definitely the only medication that has worked for me and I highly recommend it to others suffering from BV.

4.7

Patient Review

10/29/2022

Metronidazole for infection caused by bacteria

The taste of this medicine is my only complaint, but it's an otherwise effective treatment that helped me feel better within a day.

4

Patient Review

5/21/2022

Metronidazole for Infection caused by the Bacteria Anaerobes

Though the treatment itself was effective, I experienced some very unpleasant side effects. Bitter taste in my mouth and constant nausea being the worst. I also felt dizzy and like I had developed another sickness on top of what I was already treating.

4

Patient Review

7/3/2022

Metronidazole for Vaginosis caused by Bacteria

This helped my bv a lot. No more bad smell down there which is great. The affects from the pill though weâ??re horrible. Constantly nauseous, feeling like I was gonna throw up. I was super tired, disoriented, dizzy and bad headaches. I wish I got another pill because the affects were so bad for me.

4

Patient Review

7/15/2022

Metronidazole for Infection that causes Diarrhea - Giardiasis

I'm 81 and this medication started working within two days. I've been taking it for six days now, 500mg twice a day, and slowly but surely the problem is subsiding. So far no negative side effects to report.

3.3

Patient Review

6/2/2022

Metronidazole for infection caused by bacteria

The symptoms of my BV started clearing up quickly, but the taste of the medicine and the headaches it caused were tough to deal with.

3

Patient Review

10/4/2022

Metronidazole for Vaginosis caused by Bacteria

I was on the pill for 7 days, and I was so excited to be done with it! This medicine caused me to have mental issues. It does work but it made me feel like a psycho. Also, the metallic taste is unbearable. This medicine also causes nausea; had to drink chamomile tea to decrease the nausea symptoms.

2.7

Patient Review

8/15/2022

Metronidazole for Diverticulitis

The side effects of this medication were really troublesome. I had a lot of difficulty concentrating and speaking, felt irritable all the time, and was sensitive to sound. Insomnia was also an issue.

2.3

Patient Review

8/30/2022

Metronidazole for infection caused by bacteria

I developed an infection in my womb after having a polyp removed. The doctor prescribed me 400mg to be taken three times a day, but after only four days on the medication I thought I had overdosed. This drug is too powerful for me and I refused to take any more, regardless of what the doctor said. You must know your own body and listen to your intuition when it comes to taking medications.

2

Patient Review

7/16/2022

Metronidazole for Inflammation of the Stomach Lining caused by H. Pylori

While this medication did kill my h. pylori infection, I have been feeling really off since taking it. Two months in and I'm struggling with constant pressure/motion sickness and a general sense that something is not right. I don't feel like myself at all.

2

Patient Review

9/19/2022

Metronidazole for infection caused by bacteria

I'm not sure if this is helping. I've lost my sense of taste and have cramping and pain when urinating--to the point where sex is numbing. I hope things go back to normal soon.

2

Patient Review

7/14/2022

Metronidazole for Vaginosis caused by Bacteria

After taking the meds for a few days, I started to notice some concerning side effects like tingling and tenderness on my hip and upper thigh, lethargy, stiffness, anxiousness & trouble breathing. I stopped taking the medication and made my nurse practitioner aware. So far, I haven't received an alternative treatment plan; however, I will never take this drug again.

1.7

Patient Review

9/12/2022

Metronidazole for Diverticulitis

The doctor prescribed this for me, and I took it twice a day for seven days. The first two days were really tough because of the bad taste and diarrhea. By the fifth day, though, I finally saw some relief. I wouldn't want to go through that again, but it did help kill the bacteria.

1

Patient Review

5/29/2022

Metronidazole for Infection Within the Abdomen

I had an incredibly itchy rash all over my body that lasted for more than a week after taking just two pills.

1

Patient Review

6/8/2022

Metronidazole for Diabetic Foot Infection

This was a terrible experience. Two hours after application and my skin felt like it was on fire.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about metronidazole

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What bacterial infections does metronidazole treat?

"-Skin tissue infection due to Peptostreptococcus bacteria -Acute intestinal infection due to Entamoeba histolytica -Prevention of perioperative infection -Liver abscess caused by Entamoeba histolytica -Infection caused by the parasite Balantidium"

Answered by AI

What kind of antibiotic is metronidazole?

"Metronidazole is an antibiotic belonging to the nitroimidazole class that is commonly used to treat gastrointestinal infections, trichomoniasis, giardiasis, and amebiasis."

Answered by AI

What STD is metronidazole 500mg used for?

"Trichomoniasis is a sexually transmitted infection that is most commonly treated with the antibiotic metronidazole. Metronidazole is very effective when taken as prescribed."

Answered by AI

What is metronidazole used for treating?

"The medication metronidazole comes in capsules and tablets, and is used to treat infections in various parts of the body including the reproductive system, gastrointestinal tract, skin, heart, bone, joint, lung, blood, nervous system, and other areas. Metronidazole is also used to treat sexually transmitted diseases (STDs)."

Answered by AI

Clinical Trials for Metronidazole

Image of Boise VA Medical Center in Boise, United States.

Pharmacist-Led E-Consults for Lung Health in HIV

18+
All Sexes
Boise, ID

People with HIV (PWH) continue to experience elevated risk of community-acquired pneumonia despite effective antiretroviral therapy. Pneumonia contributes to hospitalization, respiratory failure, cardiovascular complications, long-term decline in lung function, and mortality. Several modifiable factors increase this risk, including active smoking, inadequate receipt of respiratory vaccinations, and inappropriate or prolonged use of inhaled corticosteroids (ICS) or proton-pump inhibitors (PPIs). OPTIMIZE Lung-HIV is a multicenter, patient-level randomized controlled hybrid Type 1 effectiveness-implementation trial evaluating whether a proactive, pharmacist-led E-consult intervention can improve evidence-based pulmonary pharmacotherapy for PWH. Pharmacists will review electronic health records, generate tailored recommendations, and pre-enter orders related to smoking cessation pharmacotherapy, vaccinations, and deprescribing of ICS or PPIs. Providers may enact or modify recommendations as clinically appropriate. The trial will assess the proportion of recommendations enacted within 3 months (primary outcome) and at 12 months (maintenance) and will use mixed methods guided by CFIR and RE-AIM to evaluate adoption, feasibility, acceptability, and implementation barriers and facilitators.

Waitlist Available
Has No Placebo

Boise VA Medical Center (+2 Sites)

Kristina A. Crothers, MD

Have you considered Metronidazole clinical trials?

We made a collection of clinical trials featuring Metronidazole, we think they might fit your search criteria.
Go to Trials
Image of Corvus Clinical Trials in South San Francisco, United States.

Soquelitinib for Eczema

18+
All Sexes
South San Francisco, CA

The main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pill with no medicine in it). To check this, the study doctors will examine participants' skin regularly to track how their AD changes during the study. The study doctors will see how safe soquelitinib is by tracking side effects among participants. They will also check "tolerability," which means how well the participants can handle soquelitinib and whether any potential side effects are manageable for them. To understand how well soquelitinib works, it will be compared with a placebo. Placebo is a substance that looks like soquelitinib but contains no active medicine in it. Participants will: * Take study treatment (soquelitinib or placebo) every day for 12 weeks * Visit the clinic for check-ups and tests every week for the first 2 weeks then every 2 weeks during the treatment period, and then return for follow-up visits 30, 60, and 90 days after the last dose of study treatment

Phase 2
Recruiting

Corvus Clinical Trials

Isin Sinem Bagci, MD

Corvus Pharmaceuticals, Inc.

Image of ALS Global in Irving, United States.

GX-03 for Eczema

18 - 70
All Sexes
Irving, TX

This is a randomized, double-blind, vehicle-controlled clinical study designed to evaluate the efficacy and safety of GX-03, a topically applied emollient, in adult subjects with moderate to severe eczema. Approximately 120 adult participants will be enrolled and randomized in a 1:1 ratio to receive either GX-03 or a petrolatum-based vehicle control for 8 consecutive weeks. Efficacy will be assessed using validated clinical outcome measures, including the Eczema Area and Severity Index (EASI), the Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™), and the Peak Pruritus Numeric Rating Scale (PP-NRS). Safety will be evaluated through monitoring of treatment-emergent adverse events throughout the study period.

Phase 2
Recruiting

ALS Global

Turn Therapeutics

Image of Seeding Labs INC in Austin, United States.

Tailored Recommendations for Infant Gut Microbiome

No minimum age - 3
All Sexes
Austin, TX

The goal of this clinical trial is to learn whether microbiome analysis, education, and personalized recommendations can improve gut health and reduce early markers of immune-related conditions in infants aged 0-3 months delivered via Cesarean section. The study aims to determine whether these interventions can increase beneficial bacteria, decrease C-section-associated microbiome signatures, reduce opportunistic pathogens, and improve functional potential for HMO digestion and SCFA production. The study also seeks to assess whether improvements in microbiome composition are associated with a reduced prevalence of early atopic symptoms. Researchers will compare three groups: a full intervention arm that receives microbiome reports, coaching, personalized recommendations, and educational materials; a limited intervention arm that receives simplified reports and basic recommendations; and a control arm that receives no results until study completion. This design allows evaluation of both a comprehensive intervention and a more scalable, minimal-results model. Participants will: 1. Provide six microbiome stool samples over a 24-month period. 2. Provide additional small stool samples at two timepoints for exploratory metabolomic analysis. 3. Receive microbiome reports and guidance according to their assigned study arm. 4. Complete surveys on infant health history, symptoms, diet, and environmental exposures. 5. Participate in standardized eczema assessment(s) administered by a Nurse Practitioner and evaluated by a Pediatric Allergy Specialist if any symptoms are reported. This study seeks to demonstrate that targeted microbiome support can positively shift gut microbial development in C-section infants and may reduce risks linked to the early stages of the atopic march. Findings may inform scalable strategies for delivering microbiome-based support in early life and improve long-term health outcomes for this high-risk population.

Recruiting
Has No Placebo

Seeding Labs INC

Qian Yuan, MD

Seeding, Inc DBA Tiny Health

Image of Children's of Alabama in Birmingham, United States.

Antibiotic Duration for Infections in Children

60 - 17
All Sexes
Birmingham, AL

Infections like pneumonia, skin and soft tissue infection (also called SSTI or cellulitis), and urinary tract infections (UTI) are some of the most common reasons children get admitted to the hospital. All three of these conditions require antibiotics for treatment. Although antibiotics are needed to treat the infection and help children feel better, taking them longer than needed can negatively impact children and their families. Negative impacts include things like the burdens of taking more medications and medication side effects. There are guidelines (instructions) from expert medical organizations that suggest the number of days children need antibiotics, but they give a wide range (between 5 and 14 days). Unfortunately, these guidelines are not based on high-quality studies. National data suggests that doctors often choose on the higher end of this range when writing prescriptions for children in the hospital. Our three caregiver co-investigators, other parents of hospitalized children, doctors, other care providers, and researchers, all believe that additional study is needed to determine the best length of antibiotic treatment that weighs both the benefits and harms of antibiotics. The goal of our study is to understand if 5 total days of antibiotic treatment compared to 10 total days of antibiotic treatment is better for children who have been in the hospital for pneumonia, SSTI, or UTI. We will study this question through a randomized control trial. In other words, half of the children will receive 5-days of antibiotics and the other half will receive 10-days of antibiotics. Children in this study (and their caregivers) will not know how many days of antibiotics they will receive to cure their infection because some children will take a placebo (or a pill without antibiotics in it). Only the pharmacy will know if a child is getting antibiotic or placebo (for days 6-10 of treatment). During the first phase of the trial (feasibility phase), 4 hospitals will enroll children in the study. We plan on enrolling 50 patients during this phase. We are starting with just 4 hospitals, so our study team can create and update our study plans if needed. We will closely review information about how many patients and families agree to participate, and if they have any trouble completing any part of the study. We will also interview families to understand the choice to participate in the study, the choice not to participate in the study, and what it is like to be in the study. During the second study phase, we will enroll 1150 more patients across all 11 hospitals. Families will complete short, daily surveys until the 15th day after they started antibiotics, then a larger survey at day 15, at day 20, and at day 30. These surveys will ask about the child's symptoms and recovery from their illness, how the antibiotics are making them feel, and if they had to go back to their doctor, emergency room, or hospital. The answers to these questions will be combined to measure how well the child did, balancing feeling better and having bad effects from the antibiotics. We will use mathematical tests to determine which antibiotic duration is better for treating these illnesses. We will complete other mathematical tests to see if all children should receive the same length of antibiotics or if certain children should be prescribed shorter courses and others longer courses.

Phase 4
Waitlist Available

Children's of Alabama (+9 Sites)

Sunitha V Kaiser, MD, MSc

Have you considered Metronidazole clinical trials?

We made a collection of clinical trials featuring Metronidazole, we think they might fit your search criteria.
Go to Trials

Have you considered Metronidazole clinical trials?

We made a collection of clinical trials featuring Metronidazole, we think they might fit your search criteria.
Go to Trials